HSBC Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

HSBC Holdings’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,241	Closed	-$18K	–	3235
2022 Q3	$18K	Sell	15,241 -10,882	-42%	-$11.7K	﹤0.01%	2874
2022 Q2	$17K	Hold	26,123	–	–	﹤0.01%	3201
2022 Q1	$29K	Hold	26,123	–	–	﹤0.01%	3227
2021 Q4	$60K	Hold	26,123	–	–	﹤0.01%	3193
2021 Q3	$90K	Hold	26,123	–	–	﹤0.01%	2894
2021 Q2	$80K	Buy	26,123 +4,951	+23%	+$15.7K	﹤0.01%	2868
2021 Q1	$69K	Buy	+21,172	New	+$70.6K	﹤0.01%	2653

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

HSBC Holdings's INFI Position: Q4 2022 in Review

HSBC Holdings sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 15,241 shares — an estimated $18K sold.

HSBC Holdings first reported a position in INFI in Q1 2021 and held it in 7 quarters. The position peaked at $90K in Q3 2021. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

HSBC Holdings reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
HSBC Holdings sold 15,241 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $18K.
HSBC Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 7 quarters.
HSBC Holdings's Infinity Pharmaceuticals, Inc. position peaked at $90K in Q3 2021.
68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.